Biovica International AB (publ) (STO:BIOVIC.B)
Sweden · Delayed Price · Currency is SEK 0.3190
-0.0130 (-3.92%)
At close: Apr 24, 2026
Biovica International AB Market Cap
Biovica International AB has a market cap or net worth of 93.12 million as of April 24, 2026. Its market cap has increased by 1.85% in one year.
Market Cap
93.12M
Enterprise Value
9.73M
Revenue
10.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.32
Market Cap Chart
Since March 29, 2017, Biovica International AB's market cap has decreased from 210.00M to 93.12M, a decrease of -55.66%. That is a compound annual growth rate of -8.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 96.91M | -10.27% |
| Dec 30, 2025 | 108.01M | -44.77% |
| Dec 30, 2024 | 195.57M | -9.82% |
| Dec 29, 2023 | 216.86M | -41.83% |
| Dec 30, 2022 | 372.79M | -68.37% |
| Dec 30, 2021 | 1.18B | -18.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NextCell Pharma AB | 133.67M |
| IRLAB Therapeutics AB | 125.88M |
| Simris Group AB (PUBL) | 120.67M |
| Annexin Pharmaceuticals AB | 106.59M |
| Scandinavian ChemoTech AB | 104.62M |
| Magle Chemoswed Holding AB | 94.99M |
| Alzinova AB | 89.41M |
| OncoZenge AB | 82.74M |